國新健康(000503.SZ):預計上半年淨虧損約8200萬元
格隆匯7月13日丨國新健康(000503.SZ)公佈,預計上半年淨虧損約8200萬元,扣非淨虧損約8,775萬元,營業收入約10,000萬元。
公司業務整體呈現前低後高的季節性特徵,報吿期內,公司堅定“一體兩翼”的戰略佈局,一方面着力提升“一體”即數字醫保板塊的專業服務能力,鞏固行業地位;另一方面加快“兩翼”即數字醫療及數字醫藥板塊的投入,不斷優化和完善產品體系。報吿期內,公司實現營業收入約人民幣1億元,同比增速約22%,主要為數字醫保板塊收入同比增長;公司營業總成本同比增速約16%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.